209 related articles for article (PubMed ID: 26437643)
1. Recent advance in molecular angiogenesis in glioblastoma: the challenge and hope for anti-angiogenic therapy.
Zhang M; Ye G; Li J; Wang Y
Brain Tumor Pathol; 2015 Oct; 32(4):229-36. PubMed ID: 26437643
[TBL] [Abstract][Full Text] [Related]
2. Tumor Development and Angiogenesis in Adult Brain Tumor: Glioblastoma.
Ahir BK; Engelhard HH; Lakka SS
Mol Neurobiol; 2020 May; 57(5):2461-2478. PubMed ID: 32152825
[TBL] [Abstract][Full Text] [Related]
3. Aspirin Affects Tumor Angiogenesis and Sensitizes Human Glioblastoma Endothelial Cells to Temozolomide, Bevacizumab, and Sunitinib, Impairing Vascular Endothelial Growth Factor-Related Signaling.
Navone SE; Guarnaccia L; Cordiglieri C; Crisà FM; Caroli M; Locatelli M; Schisano L; Rampini P; Miozzo M; La Verde N; Riboni L; Campanella R; Marfia G
World Neurosurg; 2018 Dec; 120():e380-e391. PubMed ID: 30144594
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of tumor development and anti-angiogenic therapy in glioblastoma multiforme.
Onishi M; Kurozumi K; Ichikawa T; Date I
Neurol Med Chir (Tokyo); 2013; 53(11):755-63. PubMed ID: 24162241
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic Targeting of the Notch Pathway in Glioblastoma Multiforme.
Gersey Z; Osiason AD; Bloom L; Shah S; Thompson JW; Bregy A; Agarwal N; Komotar RJ
World Neurosurg; 2019 Nov; 131():252-263.e2. PubMed ID: 31376551
[TBL] [Abstract][Full Text] [Related]
6. The gain-of-function GLI1 transcription factor TGLI1 enhances expression of VEGF-C and TEM7 to promote glioblastoma angiogenesis.
Carpenter RL; Paw I; Zhu H; Sirkisoon S; Xing F; Watabe K; Debinski W; Lo HW
Oncotarget; 2015 Sep; 6(26):22653-65. PubMed ID: 26093087
[TBL] [Abstract][Full Text] [Related]
7. Angiopoietin-4 promotes glioblastoma progression by enhancing tumor cell viability and angiogenesis.
Brunckhorst MK; Wang H; Lu R; Yu Q
Cancer Res; 2010 Sep; 70(18):7283-93. PubMed ID: 20823154
[TBL] [Abstract][Full Text] [Related]
8. Anti-angiogenic gene therapy of malignant glioma.
Stratmann A; Machein MR; Plate KH
Acta Neurochir Suppl; 1997; 68():105-10. PubMed ID: 9233424
[TBL] [Abstract][Full Text] [Related]
9. FRAT1 promotes the angiogenic properties of human glioblastoma cells via VEGFA.
Yang B; Liu D; Ren YQ; Sun YQ; Zhang JP; Wang XG; Wu YQ; Wang SL; Guo SH; Guo G
Mol Med Rep; 2022 Mar; 25(3):. PubMed ID: 35059733
[TBL] [Abstract][Full Text] [Related]
10. Advances in Experimental Targeted Therapy and Immunotherapy for Patients with Glioblastoma Multiforme.
Polivka J; Polivka J; Holubec L; Kubikova T; Priban V; Hes O; Pivovarcikova K; Treskova I
Anticancer Res; 2017 Jan; 37(1):21-33. PubMed ID: 28011470
[TBL] [Abstract][Full Text] [Related]
11. Modulation of cerebral endothelial cell function by TGF-β in glioblastoma: VEGF-dependent angiogenesis versus endothelial mesenchymal transition.
Krishnan S; Szabo E; Burghardt I; Frei K; Tabatabai G; Weller M
Oncotarget; 2015 Sep; 6(26):22480-95. PubMed ID: 26090865
[TBL] [Abstract][Full Text] [Related]
12. Anti-angiogenic gene therapy in the treatment of malignant gliomas.
Gatson NN; Chiocca EA; Kaur B
Neurosci Lett; 2012 Oct; 527(2):62-70. PubMed ID: 22906922
[TBL] [Abstract][Full Text] [Related]
13. [Topics for antiangiogenic therapy for glioblastoma].
Takano S; Matsumura A
No Shinkei Geka; 2012 Jun; 40(6):481-502. PubMed ID: 22647508
[No Abstract] [Full Text] [Related]
14. Hypoxia upregulates HIG2 expression and contributes to bevacizumab resistance in glioblastoma.
Mao XG; Wang C; Liu DY; Zhang X; Wang L; Yan M; Zhang W; Zhu J; Li ZC; Mi C; Tian JY; Hou GD; Miao SY; Song ZX; Li JC; Xue XY
Oncotarget; 2016 Jul; 7(30):47808-47820. PubMed ID: 27329597
[TBL] [Abstract][Full Text] [Related]
15. Anti-VEGF therapies for malignant glioma: treatment effects and escape mechanisms.
Miletic H; Niclou SP; Johansson M; Bjerkvig R
Expert Opin Ther Targets; 2009 Apr; 13(4):455-68. PubMed ID: 19335067
[TBL] [Abstract][Full Text] [Related]
16. Reactive oxygen species production has a critical role in hypoxia-induced Stat3 activation and angiogenesis in human glioblastoma.
Yu MO; Park KJ; Park DH; Chung YG; Chi SG; Kang SH
J Neurooncol; 2015 Oct; 125(1):55-63. PubMed ID: 26297045
[TBL] [Abstract][Full Text] [Related]
17. Knocking down galectin 1 in human hs683 glioblastoma cells impairs both angiogenesis and endoplasmic reticulum stress responses.
Le Mercier M; Mathieu V; Haibe-Kains B; Bontempi G; Mijatovic T; Decaestecker C; Kiss R; Lefranc F
J Neuropathol Exp Neurol; 2008 May; 67(5):456-69. PubMed ID: 18431251
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of neovascularization and resistance to anti-angiogenic therapies in glioblastoma multiforme.
Soda Y; Myskiw C; Rommel A; Verma IM
J Mol Med (Berl); 2013 Apr; 91(4):439-48. PubMed ID: 23512266
[TBL] [Abstract][Full Text] [Related]
19. The role of STAT3 in glioblastoma progression through dual influences on tumor cells and the immune microenvironment.
Chang N; Ahn SH; Kong DS; Lee HW; Nam DH
Mol Cell Endocrinol; 2017 Aug; 451():53-65. PubMed ID: 28089821
[TBL] [Abstract][Full Text] [Related]
20. Oct-3/4 promotes tumor angiogenesis through VEGF production in glioblastoma.
Takahashi H; Inoue A; Kawabe Y; Hosokawa Y; Iwata S; Sugimoto K; Yano H; Yamashita D; Harada H; Kohno S; Ohue S; Ohnishi T; Tanaka J
Brain Tumor Pathol; 2015 Jan; 32(1):31-40. PubMed ID: 25348671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
